HOME >> BIOLOGY >> NEWS
Biotech Foods Ready For Primetime, Experts Say

WEST LAFAYETTE, Ind. -- For many of your favorite foods, the future has arrived.

Genetic engineering, long the focus of anticipation and discussion in American agriculture, entered the realm of reality in a big way in 1998. The fact is that if in the past year you've topped a sandwich with cheese, gobbled down a bowl of cereal, or guzzled a soft drink, chances are that you've eaten foods from genetically modified crops.

Although people in agriculture have been heralding the promise of genetically enhanced crops for 20 years, few products made it to market. Quietly, over the past three years, that has changed in a major way. Marshall Martin, professor of agricultural economics and director of Purdue University's Center for Agricultural Policy and Technology Assessment, says that many common foods now use biotechnology in their production and processing.

"The genetically engineered enzyme chymosin is used in two-thirds to three-quarters of the cheese produced," Martin says. "Bt-corn, which allows the corn plants to resist the corn borer, has found wide acceptance. So everyone is already eating foods produced through biotechnology."

In fact, the use of genetically enhanced corn has increased from 400,000 acres in 1996 to three million acres in 1997 to an estimated 17 million acres planted in 1998. Each year, total corn acreage in the United States is about 80 million acres.

Biotechnology is used to produce some of our most common foods:

  • Corn produced through biotechnology is being used in many familiar foods, including breakfast cereals and taco shells. It also is used to make corn syrup, which is used as a sweetener in many foods such as soft drinks, baked goods and candies.
  • Soybeans are used in hundreds of food products, including cooking oil, candies and margarine. In 1997, about 20 million acres of the soybeans planted in the United States were genetically enhanced. Pr
    '"/>


Contact: Steve Tally
tally@aes.purdue.edu
765-494-9809
Purdue University
10-Sep-1998


Page: 1 2 3

Related biology news :

1. Nanosphere announces genetic detection advance in Nature Biotechnology
2. Leroy Hood to receive 2004 Biotechnology Heritage Award
3. Christopher Walsh wins 2004 Promega Biotechnology Research Award
4. Advancing Biotechnology Breakthroughs
5. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
6. Quark Biotech generates a cholesterol-free mouse
7. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
8. US-EC Biotech Task Force keys on research, collaboration
9. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
10. Biotechnology taught as a tool for teaching
11. Biotech regulations impede crop domestication

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech Foods Ready For Primetime Experts Say

(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/7/2015)... 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... mobile commerce market announces a revised version of one of its ... will air on CNBC in New York , ... and San Francisco metro areas.    ... Wocket,s ability to replace all the cards in your wallet and ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
(Date:7/29/2015)... , ... July 29, 2015 , ... The third Medical ... combination products , in particular, drug/device combinations. The current system received a score ... Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi ... Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is specialized in ... core expertise of PRC Clinical is focused on Clinical Trial Management, Clinical Site ...
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... Costello ... new levee system to protect the Orange County, Texas area from future storm ... multi-firm design team in determining several potential levee alignment alternatives for providing protection, Costello ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2
Cached News: